Vitasora Health Limited has released a press release.
FDA update
Filed with ASX ·
On 6ix: 6ix.com/news/fda-update-3
6ix hasn’t read this filing yet.
Vitasora Health Limited on 6ix
Story so far
Earlier from Vitasora Health
- FDA submission to be lodged
- Cancellation of shares and options
- SaaS model & First 500 devices
- CE Mark, manufacturer & clinical study agreement
- Chairmans Address to Shareholders
Later from Vitasora Health
- First batch of wheezos delivered
- Placement - investor presentation
- Placement completed
- Joint Development Agreement signed with Phenix Health
- Security Purchase Plan - Completed
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health